HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Losartan as therapy for recessive dystrophic epidermolysis bullosa: Report of three cases.

AuthorsMaria Relvas, Ana Carolina Figueiredo, Rebeca Calado, Joana Calvão, Leonor Ramos
JournalDermatologic therapy (Dermatol Ther) Vol. 35 Issue 9 Pg. e15678 (09 2022) ISSN: 1529-8019 [Electronic] United States
PMID35770627 (Publication Type: Case Reports, Letter)
Chemical References
  • Losartan
Topics
  • Epidermolysis Bullosa
  • Epidermolysis Bullosa Dystrophica (diagnosis, drug therapy)
  • Humans
  • Losartan (therapeutic use)
  • Skin

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: